ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
WP2877	Vitamin D receptor pathway	18/185	143/6030	2.84309758560184e-07	7.39205372256479e-05	7.36212637955845e-05	604/820/634/78989/1543/1591/168002/1946/727936/9173/27035/6279/6280/219855/25928/79689/8600/54210	18
WP2848	Pluripotent stem cell differentiation pathway	6/185	34/6030	0.000505165419862994	0.0656715045821893	0.0654056280454193	3577/22943/2246/10637/7018/8600	6
WP1423	Ganglio sphingolipid metabolism	3/185	10/6030	0.00290766640898901	0.251997755445714	0.250977521617999	8708/30815/6489	3
WP3527	Pre-implantation embryo	5/185	35/6030	0.00395613864103788	0.257149011667463	0.2561079225514	366/1958/2354/4603/7004	5
WP5188	Retinol metabolism	3/185	12/6030	0.00509454753144083	0.264916471634923	0.263843935312515	1543/10170/195814	3
WP24	Peptide GPCRs	5/185	41/6030	0.00787624901177836	0.315802934902412	0.314524380510095	3577/2358/4886/4887/5540	5
WP5083	Neuroinflammation and glutamatergic signaling	9/185	115/6030	0.0085023867089111	0.315802934902412	0.314524380510095	816/1610/2893/2904/2918/7850/6506/6513/92745	9
WP455	GPCRs, class A rhodopsin-like	9/185	118/6030	0.00999693722836143	0.324900459921747	0.323585073444331	1238/136/3577/2358/2852/3357/4886/4887/5540	9
WP2840	Hair follicle development: cytodifferentiation - part 3 of 3	6/185	65/6030	0.0141742629659735	0.409478707905902	0.40782089937187	22943/2354/8456/25928/11005/7704	6
WP5094	Orexin receptor pathway	8/185	112/6030	0.0212471949600137	0.552427068960357	0.550190522122461	655/1958/2354/2904/4314/6506/6513/114088	8
WP1533	Vitamin B12 metabolism	4/185	37/6030	0.0257221746461621	0.607978673454742	0.605517221335492	3043/6288/6289/6947	4
WP4917	Proximal tubule transport	4/185	42/6030	0.0387668639079953	0.839948718006565	0.836548115909372	760/762/6513/160728	4
WP3930	EDA signaling in hair follicle development	2/185	11/6030	0.0429214473603387	0.844841128248209	0.841420718822103	22943/25928	2
WP2572	Primary focal segmental glomerulosclerosis (FSGS)	5/185	65/6030	0.048371493440928	0.844841128248209	0.841420718822103	816/22943/84623/4868/5329	5
WP4698	Vitamin D-sensitive calcium signaling in depression	3/185	29/6030	0.0578964105111531	0.844841128248209	0.841420718822103	793/2904/3786	3
WP3958	GPR40 pathway	2/185	13/6030	0.0584890011864145	0.844841128248209	0.841420718822103	5333/113026	2
WP4723	Omega-3 / omega-6 fatty acid synthesis	2/185	13/6030	0.0584890011864145	0.844841128248209	0.841420718822103	9415/5322	2
WP4724	Omega-9 fatty acid synthesis	2/185	13/6030	0.0584890011864145	0.844841128248209	0.841420718822103	79071/9415	2
WP5115	Network map of SARS-CoV-2 signaling pathway	10/185	190/6030	0.0664102749775858	0.869626741600104	0.866105985561237	9332/3577/1958/3043/10410/7850/6288/6289/5104/7018	10
WP3971	OSX and miRNAs in tooth development	2/185	14/6030	0.0668943647384695	0.869626741600104	0.866105985561237	655/22943	2
WP3624	Lung fibrosis	4/185	52/6030	0.0743099129771299	0.892595046551966	0.888981301424225	655/2246/727897/729238	4
WP5053	Development of ureteric collection system	4/185	53/6030	0.0785409063246982	0.892595046551966	0.888981301424225	655/168667/9620/3237	4
WP247	Small ligand GPCRs	2/185	16/6030	0.0847883332161515	0.892595046551966	0.888981301424225	9294/1903	2
WP117	GPCRs, other	3/185	37/6030	0.103363930708713	0.892595046551966	0.888981301424225	9620/3577/2918	3
WP5149	Lipid metabolism in senescent cells	2/185	18/6030	0.103931327295671	0.892595046551966	0.888981301424225	8399/5322	2
WP43	Oxidation by cytochrome P450	3/185	38/6030	0.109816834017042	0.892595046551966	0.888981301424225	1543/1591/339761	3
WP383	Striated muscle contraction pathway	2/185	21/6030	0.134524547248923	0.892595046551966	0.888981301424225	7134/7273	2
WP4341	Non-genomic actions of 1,25 dihydroxyvitamin D3	4/185	68/6030	0.155037785891241	0.892595046551966	0.888981301424225	816/820/1591/5333	4
WP2865	IL1 and megakaryocytes in obesity	2/185	23/6030	0.155897771755551	0.892595046551966	0.888981301424225	6280/8991	2
WP3658	Wnt/beta-catenin signaling pathway in leukemia	2/185	23/6030	0.155897771755551	0.892595046551966	0.888981301424225	22943/7704	2
WP129	Matrix metalloproteinases	2/185	24/6030	0.166814197077975	0.892595046551966	0.888981301424225	4326/4314	2
WP26	S1P receptor signal transduction	2/185	24/6030	0.166814197077975	0.892595046551966	0.888981301424225	9294/1903	2
WP5205	Clock-controlled autophagy in bone metabolism	4/185	71/6030	0.172863280922205	0.892595046551966	0.888981301424225	79365/22943/5187/8600	4
WP4900	Purinergic signaling	2/185	25/6030	0.177858169566786	0.892595046551966	0.888981301424225	136/286530	2
WP176	Folate metabolism	3/185	48/6030	0.181670088182446	0.892595046551966	0.888981301424225	3043/6288/6289	3
WP558	Complement and coagulation cascades	3/185	48/6030	0.181670088182446	0.892595046551966	0.888981301424225	1191/5329/5104	3
WP241	One-carbon metabolism	2/185	26/6030	0.189011723520065	0.892595046551966	0.888981301424225	23382/10840	2
WP299	Nuclear receptors in lipid metabolism and toxicity	2/185	26/6030	0.189011723520065	0.892595046551966	0.888981301424225	8647/1591	2
WP4875	Disruption of postsynaptic signaling by CNV	2/185	26/6030	0.189011723520065	0.892595046551966	0.888981301424225	816/2904	2
WP2806	Complement system	4/185	75/6030	0.197662335231146	0.892595046551966	0.888981301424225	2214/5329/729238/11326	4
WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	6/185	128/6030	0.199134554161998	0.892595046551966	0.888981301424225	1958/9734/3359/5452/7018/11076	6
WP2882	Nuclear receptors meta-pathway	11/185	268/6030	0.199470244829961	0.892595046551966	0.888981301424225	8647/1543/1958/9982/55554/81706/9588/6286/6513/160728/11254	11
WP5113	Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway	2/185	27/6030	0.200257864603428	0.892595046551966	0.888981301424225	4314/27035	2
WP4481	Resistin as a regulator of inflammation	2/185	28/6030	0.211580527693933	0.892595046551966	0.888981301424225	5333/113026	2
WP408	Oxidative stress response	2/185	29/6030	0.222964536374139	0.892595046551966	0.888981301424225	1543/27035	2
WP2406	Cardiac progenitor differentiation	2/185	31/6030	0.245860096393279	0.892595046551966	0.888981301424225	22943/55897	2
WP3584	MECP2 and associated Rett syndrome	3/185	56/6030	0.245964807900337	0.892595046551966	0.888981301424225	604/2893/54715	3
WP4018	Clear cell renal cell carcinoma pathways	4/185	83/6030	0.250099925365407	0.892595046551966	0.888981301424225	79365/3099/197257/6513	4
WP3298	Melatonin metabolism and effects	2/185	32/6030	0.257345395774084	0.892595046551966	0.888981301424225	1543/5187	2
WP4823	Genes controlling nephrogenesis	2/185	32/6030	0.257345395774084	0.892595046551966	0.888981301424225	3237/4868	2
WP2007	Iron metabolism in placenta	1/185	10/6030	0.267901793279446	0.892595046551966	0.888981301424225	7018	1
WP4259	Disorders of folate metabolism and transport	1/185	10/6030	0.267901793279446	0.892595046551966	0.888981301424225	10840	1
WP4389	Bile acids synthesis and enterohepatic circulation 	1/185	10/6030	0.267901793279446	0.892595046551966	0.888981301424225	8647	1
WP15	Selenium micronutrient network	3/185	59/6030	0.270968300437617	0.892595046551966	0.888981301424225	3043/6288/6289	3
WP4008	NO/cGMP/PKG mediated neuroprotection	2/185	34/6030	0.280331021491139	0.892595046551966	0.888981301424225	816/2904	2
WP2884	NRF2 pathway	5/185	116/6030	0.283486571813876	0.892595046551966	0.888981301424225	1958/9588/6513/160728/11254	5
WP4271	Vitamin B12 disorders	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	6947	1
WP4553	FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	604	1
WP4629	Aerobic glycolysis	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	6513	1
WP4788	Autosomal recessive osteopetrosis pathways	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	8600	1
WP5052	Nephrogenesis	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	655	1
WP5191	Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution	1/185	11/6030	0.290399827871356	0.892595046551966	0.888981301424225	2358	1
WP5130	Th17 cell differentiation pathway	3/185	62/6030	0.296239016903398	0.892595046551966	0.888981301424225	50615/9572/5187	3
WP2447	Amyotrophic lateral sclerosis (ALS)	2/185	36/6030	0.303264792241494	0.892595046551966	0.888981301424225	4741/6506	2
WP4754	IL-18 signaling pathway	9/185	239/6030	0.311765312779595	0.892595046551966	0.888981301424225	2904/8870/81618/10365/4314/27035/7018/7052/8600	9
WP2023	Cell differentiation - expanded index	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	10637	1
WP2881	Estrogen receptor pathway	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	1543	1
WP3876	BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	22943	1
WP4211	Transcriptional cascade regulating adipogenesis	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	10365	1
WP5110	Familial hyperlipidemia type 3	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	7436	1
WP5173	Disorders of galactose metabolism 	1/185	12/6030	0.312210100648196	0.892595046551966	0.888981301424225	5836	1
WP2857	Mesodermal commitment pathway	5/185	121/6030	0.313618699811181	0.892595046551966	0.888981301424225	655/1466/22943/8325/10637	5
WP4148	Splicing factor NOVA regulated synaptic proteins	2/185	37/6030	0.314687698614795	0.892595046551966	0.888981301424225	1946/2904	2
WP2880	Glucocorticoid receptor pathway	3/185	65/6030	0.321648871110873	0.892595046551966	0.888981301424225	9982/81706/6286	3
WP5218	Extrafollicular B cell activation by SARS-CoV-2	3/185	65/6030	0.321648871110873	0.892595046551966	0.888981301424225	57379/60468/604	3
WP500	Glycogen synthesis and degradation	2/185	38/6030	0.326069413314671	0.892595046551966	0.888981301424225	3099/5836	2
WP185	Integrin-mediated cell adhesion	4/185	94/6030	0.326086337748562	0.892595046551966	0.888981301424225	11131/827/3681/84665	4
WP2289	Drug induction of bile acid pathway	1/185	13/6030	0.333353525603345	0.892595046551966	0.888981301424225	8647	1
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	1/185	13/6030	0.333353525603345	0.892595046551966	0.888981301424225	7134	1
WP5176	Disorders of bile acid synthesis and biliary transport	1/185	13/6030	0.333353525603345	0.892595046551966	0.888981301424225	8647	1
WP5192	Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids	1/185	13/6030	0.333353525603345	0.892595046551966	0.888981301424225	1903	1
WP3937	Microglia pathogen phagocytosis pathway	2/185	39/6030	0.337401741402029	0.892595046551966	0.888981301424225	54210/54209	2
WP5097	CCL18 signaling pathway	2/185	39/6030	0.337401741402029	0.892595046551966	0.888981301424225	6513/7004	2
WP534	Glycolysis and gluconeogenesis	2/185	39/6030	0.337401741402029	0.892595046551966	0.888981301424225	3099/6513	2
WP536	Calcium regulation in cardiac cells	5/185	125/6030	0.338028184456999	0.892595046551966	0.888981301424225	782/816/2707/5569/8787	5
WP4222	Phosphodiesterases in neuronal function	2/185	40/6030	0.34867702406165	0.892595046551966	0.888981301424225	2904/5145	2
WP4312	Rett syndrome causing genes	2/185	40/6030	0.34867702406165	0.892595046551966	0.888981301424225	2904/6334	2
WP12	Osteoclast signaling	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	8600	1
WP2879	Farnesoid X receptor pathway	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	8647	1
WP3969	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	1466	1
WP4584	Biomarkers for pyrimidine metabolism disorders	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	1152	1
WP58	Monoamine GPCRs	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	3357	1
WP697	Estrogen metabolism	1/185	14/6030	0.353850384131412	0.892595046551966	0.888981301424225	1543	1
WP5220	Metabolic reprogramming in pancreatic cancer	2/185	41/6030	0.359888113724664	0.892595046551966	0.888981301424225	3099/6513	2
WP3594	Circadian rhythm genes	6/185	159/6030	0.361937173811908	0.892595046551966	0.888981301424225	79365/1958/4887/9572/5187/60675	6
WP4673	Male infertility	4/185	100/6030	0.368285284294695	0.892595046551966	0.888981301424225	1191/1543/8787/128153	4
WP1946	Cori cycle	1/185	15/6030	0.373720344060882	0.892595046551966	0.888981301424225	6513	1
WP4522	Metabolic pathway of LDL, HDL and TG, including diseases	1/185	15/6030	0.373720344060882	0.892595046551966	0.888981301424225	255738	1
WP5109	Familial hyperlipidemia type 2	1/185	15/6030	0.373720344060882	0.892595046551966	0.888981301424225	255738	1
WP4539	Synaptic signaling pathways associated with autism spectrum disorder	2/185	43/6030	0.382091537773633	0.892595046551966	0.888981301424225	816/2904	2
WP5095	Overview of proinflammatory and profibrotic mediators	3/185	73/6030	0.389222999159861	0.892595046551966	0.888981301424225	6369/29949/4314	3
WP3664	Regulation of Wnt / B-catenin signaling by small molecule compounds	1/185	16/6030	0.392982478117197	0.892595046551966	0.888981301424225	8325	1
WP4478	LTF danger signal response pathway	1/185	16/6030	0.392982478117197	0.892595046551966	0.888981301424225	54210	1
WP410	Exercise-induced circadian regulation	2/185	44/6030	0.393071923248674	0.892595046551966	0.888981301424225	5187/10381	2
WP4971	Phosphoinositides metabolism	2/185	44/6030	0.393071923248674	0.892595046551966	0.888981301424225	5333/113026	2
WP4538	Regulatory circuits of the STAT3 signaling pathway	3/185	75/6030	0.405913421354294	0.892595046551966	0.888981301424225	1844/53832/50615	3
WP3287	Overview of nanoparticle effects	1/185	17/6030	0.411655281833246	0.892595046551966	0.888981301424225	3681	1
WP3967	miR-509-3p alteration of YAP1/ECM axis	1/185	17/6030	0.411655281833246	0.892595046551966	0.888981301424225	7004	1
WP4790	FGF23 signaling in hypophosphatemic rickets and related disorders	1/185	17/6030	0.411655281833246	0.892595046551966	0.888981301424225	1591	1
WP5074	Kallmann syndrome	1/185	17/6030	0.411655281833246	0.892595046551966	0.888981301424225	60675	1
WP691	Tamoxifen metabolism	1/185	17/6030	0.411655281833246	0.892595046551966	0.888981301424225	1543	1
WP2849	Hematopoietic stem cell differentiation	2/185	46/6030	0.414763362150454	0.892595046551966	0.888981301424225	2354/23650	2
WP4533	Transcription co-factors SKI and SKIL protein partners	1/185	18/6030	0.429756690923692	0.892595046551966	0.888981301424225	7004	1
WP4760	PKC-gamma calcium signaling pathway in ataxia	1/185	18/6030	0.429756690923692	0.892595046551966	0.888981301424225	2893	1
WP497	Urea cycle and metabolism of amino groups	1/185	18/6030	0.429756690923692	0.892595046551966	0.888981301424225	1152	1
WP734	Serotonin receptor 4/6/7 and NR3C signaling	1/185	18/6030	0.429756690923692	0.892595046551966	0.888981301424225	1958	1
WP3646	Hepatitis C and hepatocellular carcinoma	2/185	48/6030	0.436064712462887	0.892595046551966	0.888981301424225	3577/7345	2
WP2895	Differentiation of white and brown adipocyte	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	655	1
WP325	Triacylglyceride synthesis	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	56895	1
WP4142	Metabolism of spingolipids in ER and Golgi apparatus	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	8708	1
WP4206	Hereditary leiomyomatosis and renal cell carcinoma pathway	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	6513	1
WP4722	Glycerolipids and glycerophospholipids	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	56895	1
WP732	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	1/185	19/6030	0.447304098139114	0.892595046551966	0.888981301424225	3357	1
WP560	TGF-beta receptor signaling	2/185	50/6030	0.456943838855503	0.892595046551966	0.888981301424225	25805/10637	2
WP167	Eicosanoid synthesis	1/185	20/6030	0.464314369615451	0.892595046551966	0.888981301424225	5322	1
WP2878	PPAR-alpha pathway	1/185	20/6030	0.464314369615451	0.892595046551966	0.888981301424225	55554	1
WP5044	Kynurenine pathway and links to cell senescence	1/185	20/6030	0.464314369615451	0.892595046551966	0.888981301424225	7850	1
WP673	ErbB signaling pathway	3/185	83/6030	0.471125382287	0.892595046551966	0.888981301424225	816/2069/145957	3
WP1772	Apoptosis modulation and signaling	3/185	84/6030	0.479060984795286	0.892595046551966	0.888981301424225	638/8739/7850	3
WP4141	PI3K/AKT/mTOR - vitamin D3 signaling	1/185	21/6030	0.480803860733777	0.892595046551966	0.888981301424225	1591	1
WP3591	Sleep regulation	1/185	22/6030	0.496788431504996	0.892595046551966	0.888981301424225	4887	1
WP4537	Hippo-Yap signaling pathway	1/185	22/6030	0.496788431504996	0.892595046551966	0.888981301424225	7004	1
WP712	Estrogen signaling pathway	1/185	22/6030	0.496788431504996	0.892595046551966	0.888981301424225	2852	1
WP3942	PPAR signaling pathway	2/185	54/6030	0.497332670659679	0.892595046551966	0.888981301424225	9415/28965	2
WP4816	TGF-beta receptor signaling in skeletal dysplasias	2/185	54/6030	0.497332670659679	0.892595046551966	0.888981301424225	25805/10637	2
WP2858	Ectoderm differentiation	4/185	120/6030	0.505615628034214	0.892595046551966	0.888981301424225	1496/8325/5452/7704	4
WP2361	Gastric cancer network 1	1/185	23/6030	0.512283461493607	0.892595046551966	0.888981301424225	6286	1
WP34	Ovarian infertility	1/185	23/6030	0.512283461493607	0.892595046551966	0.888981301424225	1958	1
WP3893	Development and heterogeneity of the ILC family	1/185	23/6030	0.512283461493607	0.892595046551966	0.888981301424225	7704	1
WP5046	NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence	1/185	23/6030	0.512283461493607	0.892595046551966	0.888981301424225	6513	1
WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	1/185	23/6030	0.512283461493607	0.892595046551966	0.888981301424225	27035	1
WP4721	Eicosanoid metabolism via lipooxygenases (LOX)	1/185	24/6030	0.527303864294287	0.892595046551966	0.888981301424225	2358	1
WP3931	Embryonic stem cell pluripotency pathways	3/185	91/6030	0.532962936774045	0.892595046551966	0.888981301424225	2246/2256/8325	3
WP3680	Physico-chemical features and toxicity-associated pathways	2/185	58/6030	0.535769059815541	0.892595046551966	0.888981301424225	8325/4741	2
WP702	Metapathway biotransformation Phase I and II	4/185	125/6030	0.538031401458111	0.892595046551966	0.888981301424225	1543/1591/339761/64090	4
WP231	TNF-alpha signaling pathway	3/185	92/6030	0.540408537974596	0.892595046551966	0.888981301424225	27035/124056/5836	3
WP3613	Photodynamic therapy-induced unfolded protein response	1/185	25/6030	0.541864101574599	0.892595046551966	0.888981301424225	121506	1
WP4969	RAS and bradykinin pathways in COVID-19	1/185	25/6030	0.541864101574599	0.892595046551966	0.888981301424225	1591	1
WP5092	Interactions of natural killer cells in pancreatic cancer	1/185	25/6030	0.541864101574599	0.892595046551966	0.888981301424225	2214	1
WP183	Proteasome degradation	2/185	59/6030	0.545060314530556	0.892595046551966	0.888981301424225	3135/7345	2
WP5090	Complement system in neuronal development and plasticity	3/185	93/6030	0.547786317636573	0.892595046551966	0.888981301424225	1191/78989/286204	3
WP2118	Arrhythmogenic right ventricular cardiomyopathy	2/185	60/6030	0.554222094037078	0.892595046551966	0.888981301424225	782/1496	2
WP2817	Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4)	1/185	26/6030	0.555978196696781	0.892595046551966	0.888981301424225	8600	1
WP4719	Eicosanoid metabolism via cyclooxygenases (COX)	1/185	26/6030	0.555978196696781	0.892595046551966	0.888981301424225	5322	1
WP4155	Endometrial cancer	2/185	61/6030	0.563253559500709	0.892595046551966	0.888981301424225	1496/2246	2
WP4313	Ferroptosis	2/185	61/6030	0.563253559500709	0.892595046551966	0.888981301424225	27035/7018	2
WP2197	Endothelin pathways	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	4886	1
WP2525	Trans-sulfuration and one-carbon metabolism	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	23382	1
WP3869	Cannabinoid receptor signaling	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	1543	1
WP3996	Ethanol effects on histone modifications	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	9734	1
WP5038	Mitochondrial immune response to SARS-CoV-2	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	27035	1
WP5102	Familial partial lipodystrophy (FPLD)	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	10365	1
WP5121	Sphingolipid metabolism in senescence	1/185	27/6030	0.56965974793114	0.892595046551966	0.888981301424225	9294	1
WP289	Myometrial relaxation and contraction pathways	4/185	131/6030	0.575483629936881	0.892595046551966	0.888981301424225	816/5569/5333/8787	4
WP5055	Burn wound healing	3/185	97/6030	0.57659708053366	0.892595046551966	0.888981301424225	4314/6280/8796	3
WP4150	Wnt signaling in kidney disease	1/185	28/6030	0.582921941273259	0.892595046551966	0.888981301424225	8325	1
WP4561	Cell migration and invasion through p75NTR	1/185	28/6030	0.582921941273259	0.892595046551966	0.888981301424225	1946	1
WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	1/185	28/6030	0.582921941273259	0.892595046551966	0.888981301424225	8600	1
WP4838	Regucalcin in proximal tubule epithelial kidney cells	1/185	28/6030	0.582921941273259	0.892595046551966	0.888981301424225	8600	1
WP428	Wnt signaling	3/185	98/6030	0.583619838130132	0.892595046551966	0.888981301424225	816/22943/8325	3
WP2374	Oncostatin M signaling pathway	2/185	64/6030	0.589560208215175	0.896407334128336	0.892778154637938	1958/4314	2
WP2380	Brain-derived neurotrophic factor (BDNF) signaling pathway	4/185	134/6030	0.593562304598859	0.897245344161066	0.893612771917499	1958/2904/84894/10603	4
WP4549	Fragile X syndrome	3/185	101/6030	0.60424345299411	0.89796201690661	0.894326543153952	816/54869/2904	3
WP2839	Hair follicle development: organogenesis - part 2 of 3	1/185	30/6030	0.608239011113392	0.89796201690661	0.894326543153952	2246	1
WP4149	White fat cell differentiation	1/185	30/6030	0.608239011113392	0.89796201690661	0.894326543153952	10365	1
WP2636	Common pathways underlying drug addiction	1/185	31/6030	0.620318308270729	0.89796201690661	0.894326543153952	2893	1
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1/185	31/6030	0.620318308270729	0.89796201690661	0.894326543153952	9734	1
WP4241	Type 2 papillary renal cell carcinoma	1/185	31/6030	0.620318308270729	0.89796201690661	0.894326543153952	6513	1
WP2064	Neural crest differentiation	2/185	68/6030	0.622788368738729	0.89796201690661	0.894326543153952	655/9734	2
WP382	MAPK signaling pathway	6/185	210/6030	0.629650780508822	0.89796201690661	0.894326543153952	782/1844/2246/2256/7850/25780	6
WP3995	Prion disease pathway	1/185	32/6030	0.632027111899653	0.89796201690661	0.894326543153952	5452	1
WP3998	Prader-Willi and Angelman syndrome	1/185	32/6030	0.632027111899653	0.89796201690661	0.894326543153952	4948	1
WP4542	Leukocyte-intrinsic Hippo pathway functions	1/185	32/6030	0.632027111899653	0.89796201690661	0.894326543153952	7004	1
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1/185	33/6030	0.643376725820721	0.899343810287029	0.895702742229187	4314	1
WP465	Tryptophan metabolism	1/185	33/6030	0.643376725820721	0.899343810287029	0.895702742229187	1543	1
WP4756	Renin-angiotensin-aldosterone system (RAAS)	1/185	33/6030	0.643376725820721	0.899343810287029	0.895702742229187	816	1
WP4336	ncRNAs involved in Wnt signaling in hepatocellular carcinoma	2/185	72/6030	0.653913253742379	0.900202692106377	0.896558146794205	22943/8325	2
WP619	Type II interferon signaling	1/185	34/6030	0.654378110800405	0.900202692106377	0.896558146794205	2633	1
WP716	Vitamin A and carotenoid metabolism	1/185	34/6030	0.654378110800405	0.900202692106377	0.896558146794205	195814	1
WP2371	Parkinson's disease pathway	1/185	35/6030	0.665041894906796	0.900504511405836	0.89685874415318	7345	1
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	1/185	35/6030	0.665041894906796	0.900504511405836	0.89685874415318	6513	1
WP5198	Inflammatory bowel disease signaling	1/185	35/6030	0.665041894906796	0.900504511405836	0.89685874415318	50615	1
WP2873	Aryl hydrocarbon receptor pathway	1/185	36/6030	0.675378383554377	0.900504511405836	0.89685874415318	1543	1
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	1/185	36/6030	0.675378383554377	0.900504511405836	0.89685874415318	84676	1
WP4877	Host-pathogen interaction of human coronaviruses - MAPK signaling	1/185	36/6030	0.675378383554377	0.900504511405836	0.89685874415318	10410	1
WP4331	Neovascularisation processes	1/185	37/6030	0.685397569247143	0.909200857164577	0.905519882034356	94	1
WP4758	Nephrotic syndrome	1/185	38/6030	0.695109141029101	0.913858916954042	0.910159083282163	4868	1
WP4258	lncRNA in canonical Wnt signaling and colorectal cancer	2/185	78/6030	0.696737132832669	0.913858916954042	0.910159083282163	22943/8325	2
WP5124	Alzheimer's disease	6/185	226/6030	0.69945355566867	0.913858916954042	0.910159083282163	22943/8325/2904/3800/27035/10381	6
WP2853	Endoderm differentiation	3/185	118/6030	0.708030858461194	0.920374862213056	0.916648648195999	655/22943/1844	3
WP2059	Alzheimer's disease and miRNA effects	6/185	229/6030	0.711520566557016	0.920374862213056	0.916648648195999	22943/8325/2904/3800/27035/10381	6
WP4963	p53 transcriptional gene network	2/185	81/6030	0.716463501051555	0.920997979326366	0.91726924256796	136/6513	2
WP4290	Metabolic reprogramming in colon cancer	1/185	41/6030	0.722490702029251	0.920997979326366	0.91726924256796	6513	1
WP2036	TNF-related weak inducer of apoptosis (TWEAK) signaling pathway	1/185	42/6030	0.731062954512902	0.920997979326366	0.91726924256796	84676	1
WP4534	Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms	1/185	42/6030	0.731062954512902	0.920997979326366	0.91726924256796	7004	1
WP4223	Ras signaling	4/185	161/6030	0.734462796553741	0.920997979326366	0.91726924256796	2904/8399/5322/25780	4
WP2586	Aryl hydrocarbon receptor pathway	1/185	43/6030	0.739371797768599	0.920997979326366	0.91726924256796	1543	1
WP5087	Malignant pleural mesothelioma	10/185	381/6030	0.7415940451626	0.920997979326366	0.91726924256796	1496/22943/1825/1946/2246/2256/8325/4314/6513/7004	10
WP2038	Microtubule cytoskeleton regulation	1/185	44/6030	0.747425283222551	0.920997979326366	0.91726924256796	11076	1
WP2267	Synaptic vesicle pathway	1/185	44/6030	0.747425283222551	0.920997979326366	0.91726924256796	23025	1
WP4861	Endoplasmic reticulum stress response in coronavirus infection	1/185	44/6030	0.747425283222551	0.920997979326366	0.91726924256796	81706	1
WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	1/185	45/6030	0.755231217503177	0.926226964862387	0.922477058122054	9415	1
WP4262	Breast cancer pathway	3/185	129/6030	0.763325875351718	0.931759284466885	0.927986979671473	2246/8325/8600	3
WP2272	Pathogenic Escherichia coli infection	1/185	49/6030	0.784127415937443	0.946807166763388	0.942973939367584	10381	1
WP4239	Epithelial to mesenchymal transition in colorectal cancer	3/185	134/6030	0.785521646736993	0.946807166763388	0.942973939367584	8999/9073/8325	3
WP3286	Copper homeostasis	1/185	51/6030	0.797276394859417	0.946807166763388	0.942973939367584	79689	1
WP23	B cell receptor signaling pathway	2/185	96/6030	0.799585755982214	0.946807166763388	0.942973939367584	604/25780	2
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1/185	52/6030	0.803548993446306	0.946807166763388	0.942973939367584	8870	1
WP4906	3q29 copy number variation syndrome	1/185	52/6030	0.803548993446306	0.946807166763388	0.942973939367584	7018	1
WP2431	Spinal cord injury	2/185	98/6030	0.808877346418597	0.946807166763388	0.942973939367584	1958/5322	2
WP4787	Osteoblast differentiation and related diseases	2/185	98/6030	0.808877346418597	0.946807166763388	0.942973939367584	2246/8325	2
WP2795	Cardiac hypertrophic response	1/185	53/6030	0.809628524428647	0.946807166763388	0.942973939367584	9734	1
WP2018	RANKL/RANK signaling pathway	1/185	54/6030	0.815520899028061	0.946807166763388	0.942973939367584	8600	1
WP3888	VEGFA-VEGFR2 signaling pathway	10/185	409/6030	0.815710789826919	0.946807166763388	0.942973939367584	1466/22943/1958/10755/9734/3748/5322/5329/9588/7004	10
WP4541	Hippo-Merlin signaling dysregulation	2/185	101/6030	0.822099362560638	0.948921918914703	0.945080129769299	3681/7004	2
WP710	DNA damage response (only ATM dependent)	2/185	103/6030	0.830454794968565	0.948921918914703	0.945080129769299	604/638	2
WP474	Endochondral ossification	1/185	57/6030	0.832131528894432	0.948921918914703	0.945080129769299	655	1
WP4808	Endochondral ossification with skeletal dysplasias	1/185	57/6030	0.832131528894432	0.948921918914703	0.945080129769299	655	1
WP3651	Pathways affected in adenoid cystic carcinoma	1/185	58/6030	0.837330870457219	0.950681337637018	0.946832425338892	4603	1
WP304	Kit receptor signaling pathway	1/185	59/6030	0.842370017973196	0.952244368143613	0.948389127786756	10603	1
WP4659	Gastrin signaling pathway	2/185	108/6030	0.849823490806658	0.956511288353814	0.952638773016349	1958/3067	2
WP2359	Parkin-ubiquitin proteasomal system pathway	1/185	62/6030	0.856574648890974	0.959954347895057	0.956067893045279	10381	1
WP481	Insulin signaling	3/185	156/6030	0.863681393209159	0.961477264776362	0.957584644271194	1958/10603/6513	3
WP2032	Thyroid stimulating hormone (TSH) signaling pathway	1/185	64/6030	0.865329538298725	0.961477264776362	0.957584644271194	1958	1
WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/185	66/6030	0.873552729283501	0.966483870696639	0.962570980531876	820	1
WP4949	16p11.2 proximal deletion syndrome	1/185	67/6030	0.877475054079368	0.966709805341677	0.962796000461751	23025	1
WP4656	Joubert syndrome	1/185	71/6030	0.891990629467416	0.970980318567295	0.967049224160139	5145	1
WP4217	Ebola virus infection in host	2/185	124/6030	0.899060102630808	0.970980318567295	0.967049224160139	26762/3135	2
WP51	Regulation of actin cytoskeleton	2/185	127/6030	0.90643713138074	0.970980318567295	0.967049224160139	2246/2256	2
WP2328	Allograft rejection	1/185	76/6030	0.907752407068244	0.970980318567295	0.967049224160139	3135	1
WP4016	DNA IR-damage and cellular response via ATR	1/185	76/6030	0.907752407068244	0.970980318567295	0.967049224160139	604	1
WP3925	Amino acid metabolism	1/185	77/6030	0.910618682629611	0.970980318567295	0.967049224160139	3067	1
WP2355	Corticotropin-releasing hormone signaling pathway	1/185	78/6030	0.913396365094506	0.970980318567295	0.967049224160139	2354	1
WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	5/185	265/6030	0.915812486617792	0.970980318567295	0.967049224160139	1946/2246/2256/3681/6513	5
WP4022	Pyrimidine metabolism	1/185	79/6030	0.916088178343417	0.970980318567295	0.967049224160139	956	1
WP1544	MicroRNAs in cardiomyocyte hypertrophy	1/185	80/6030	0.918696762952133	0.970980318567295	0.967049224160139	9734	1
WP254	Apoptosis	1/185	84/6030	0.928348850619931	0.972225179918355	0.968289045586702	8739	1
WP4540	Hippo signaling regulation pathways	1/185	84/6030	0.928348850619931	0.972225179918355	0.968289045586702	7004	1
WP69	T-cell receptor signaling pathway	1/185	86/6030	0.932738467788662	0.972225179918355	0.968289045586702	3604	1
WP399	Wnt signaling pathway and pluripotency	1/185	87/6030	0.934831903767649	0.972225179918355	0.968289045586702	8325	1
WP4657	22q11.2 copy number variation syndrome	1/185	90/6030	0.940731248456265	0.974462647803302	0.970517454897216	150209	1
WP4658	Small cell lung cancer	1/185	93/6030	0.946099179624124	0.976134074215367	0.972182114400729	22798	1
WP5224	2q37 copy number variation syndrome	1/185	104/6030	0.96196040071298	0.988575905871047	0.98457357426833	64090	1
WP4172	PI3K-Akt signaling pathway	4/185	280/6030	0.975819285969874	0.99680419667783	0.992768552156867	1946/2246/2256/22798	4
WP3915	Angiopoietin-like protein 8 regulatory pathway	1/185	125/6030	0.98047986909585	0.99680419667783	0.992768552156867	6513	1
WP366	TGF-beta signaling pathway	1/185	130/6030	0.983352862730296	0.99680419667783	0.992768552156867	2354	1
WP4396	Nonalcoholic fatty liver disease	1/185	137/6030	0.986681998910139	0.99680419667783	0.992768552156867	125965	1
WP3929	Chemokine signaling pathway	1/185	152/6030	0.991751011864555	0.99680419667783	0.992768552156867	6369	1
WP437	EGF/EGFR signaling pathway	1/185	157/6030	0.992970334382915	0.99680419667783	0.992768552156867	2354	1
WP4352	Ciliary landscape	1/185	201/6030	0.998289867480132	0.998289867480132	0.994248208097621	4741	1
